Identification of Fragile X Syndrome Specific Molecular Markers in Human Fibroblasts: A Useful Model to Test the Efficacy of Therapeutic Drugs
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of Fragile X Syndrome Specific Molecular Markers in Human Fibroblasts: A Useful Model to Test the Efficacy of Therapeutic Drugs
Authors
Keywords
-
Journal
HUMAN MUTATION
Volume 35, Issue 12, Pages 1485-1494
Publisher
Wiley
Online
2014-09-16
DOI
10.1002/humu.22699
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epidemiology of fragile X syndrome: A systematic review and meta-analysis
- (2014) Jessica Hunter et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Promoter-Bound Trinucleotide Repeat mRNA Drives Epigenetic Silencing in Fragile X Syndrome
- (2014) D. Colak et al. SCIENCE
- Glycogen Synthase Kinase-3 Inhibitors Reverse Deficits in Long-term Potentiation and Cognition in Fragile X Mice
- (2013) Aimee V. Franklin et al. BIOLOGICAL PSYCHIATRY
- Altered Cerebral Protein Synthesis in Fragile X Syndrome: Studies in Human Subjects and Knockout Mice
- (2013) Mei Qin et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Fragile X Screening by Quantification of FMRP in Dried Blood Spots by a Luminex Immunoassay
- (2013) Giuseppe LaFauci et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Process-based expansion and neural differentiation of human pluripotent stem cells for transplantation and disease modeling
- (2013) Alexander E. Stover et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Targeting the endocannabinoid system in the treatment of fragile X syndrome
- (2013) Arnau Busquets-Garcia et al. NATURE MEDICINE
- Genetic and acute CPEB1 depletion ameliorate fragile X pathophysiology
- (2013) Tsuyoshi Udagawa et al. NATURE MEDICINE
- The translation of translational control by FMRP: therapeutic targets for FXS
- (2013) Jennifer C Darnell et al. NATURE NEUROSCIENCE
- Lovastatin Corrects Excess Protein Synthesis and Prevents Epileptogenesis in a Mouse Model of Fragile X Syndrome
- (2013) Emily K. Osterweil et al. NEURON
- Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome
- (2012) C. A. Hoeffer et al. GENES BRAIN AND BEHAVIOR
- Somatic Expansion in Mouse and Human Carriers of Fragile X Premutation Alleles
- (2012) Rachel Adihe Lokanga et al. HUMAN MUTATION
- Activation of the extracellular signal-regulated kinase pathway contributes to the behavioral deficit of fragile x-syndrome
- (2012) Xinglong Wang et al. JOURNAL OF NEUROCHEMISTRY
- Unknown
- (2012) Christina Gross et al. MOLECULAR MEDICINE
- Genetic Removal of p70 S6 Kinase 1 Corrects Molecular, Synaptic, and Behavioral Phenotypes in Fragile X Syndrome Mice
- (2012) Aditi Bhattacharya et al. NEURON
- Chronic Pharmacological mGlu5 Inhibition Corrects Fragile X in Adult Mice
- (2012) Aubin Michalon et al. NEURON
- Reversal of Disease-Related Pathologies in the Fragile X Mouse Model by Selective Activation of GABAB Receptors with Arbaclofen
- (2012) C. Henderson et al. Science Translational Medicine
- Molecular Mechanisms of Fragile X Syndrome: A Twenty-Year Perspective
- (2011) Michael R. Santoro et al. Annual Review of Pathology-Mechanisms of Disease
- Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks
- (2011) Brian Magnuson et al. BIOCHEMICAL JOURNAL
- FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism
- (2011) Jennifer C. Darnell et al. CELL
- Lithium reverses increased rates of cerebral protein synthesis in a mouse model of fragile X syndrome
- (2011) Zhong-Hua Liu et al. NEUROBIOLOGY OF DISEASE
- Reversal of Fragile X Phenotypes by Manipulation of AβPP/Aβ Levels in Fmr1KO Mice
- (2011) Cara J. Westmark et al. PLoS One
- Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1)
- (2010) Laura R. Pearce et al. BIOCHEMICAL JOURNAL
- The Fragile X Syndrome
- (2010) Edward Goldson et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- An Information-Rich CGG Repeat Primed PCR That Detects the Full Range of Fragile X Expanded Alleles and Minimizes the Need for Southern Blot Analysis
- (2010) Liangjing Chen et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Excess Phosphoinositide 3-Kinase Subunit Synthesis and Activity as a Novel Therapeutic Target in Fragile X Syndrome
- (2010) C. Gross et al. JOURNAL OF NEUROSCIENCE
- Dysregulation of mTOR Signaling in Fragile X Syndrome
- (2010) A. Sharma et al. JOURNAL OF NEUROSCIENCE
- Hypersensitivity to mGluR5 and ERK1/2 Leads to Excessive Protein Synthesis in the Hippocampus of a Mouse Model of Fragile X Syndrome
- (2010) E. K. Osterweil et al. JOURNAL OF NEUROSCIENCE
- BDNF and TrkB in neuronal differentiation of Fmr1-knockout mouse
- (2010) Verna Louhivuori et al. NEUROBIOLOGY OF DISEASE
- Fragile X: Leading the way for targeted treatments in autism
- (2010) Lulu W. Wang et al. Neurotherapeutics
- Fragile X mental retardation protein control of neuronal mRNA metabolism: Insights into mRNA stability
- (2009) Silvia De Rubeis et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Translational Control of Long-Lasting Synaptic Plasticity and Memory
- (2009) Mauro Costa-Mattioli et al. NEURON
- Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome
- (2008) Gül Dölen et al. JOURNAL OF PHYSIOLOGY-LONDON
- Fragile X Syndrome: Loss of Local mRNA Regulation Alters Synaptic Development and Function
- (2008) Gary J. Bassell et al. NEURON
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started